St. Francis Cancer Center | St. Francis Cancer Center | CerRx FEN-T14
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
clinical-trial-template-default,single,single-clinical-trial,postid-1476,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Clinical Trials

CerRx FEN-T14

Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) retinamide, 4-HPR) Emulsion for Patients with Relapsed/Refractory Peripheral T-Cell Lymphomas (PTCL). > Read More

« Available Clinical Trials